Target intelligence / Profile preview

RP42 homolog pseudogene (RP42)

Target
RP42
Molecular classification
Pseudogene
01

Overview

RP42 homolog pseudogene (ENSG00000220695), also called RP42, is classified as a pseudogene, meaning it is a genomic DNA sequence similar to a known gene but rendered non-functional due to disabling mutations. Pseudogenes do not code for functional proteins and are not considered therapeutic targets[1][5]. Although some pseudogenes are transcribed as non-coding RNAs and may have roles in gene regulation or disease, there is no evidence this specific pseudogene is relevant as a biomarker or functional gene product[1][2][3][5]. RP42 homolog pseudogene is not a valid drug target, receptor, enzyme, transporter, or gene involved in known therapeutic pathways; it is a genomically disabled, non-coding copy and not functionally characterized[1][5].

Other names
RP42 homologRP42
02

Mechanism of action

None (not a druggable target)

03

Biological functions

Other (pseudogenes typically lack biological protein-coding function but can sometimes regulate gene expression through non-coding RNA mechanisms)
04

Disease associations

Other (no direct roles in disease established for this pseudogene; however, some pseudogenes, in general, can serve regulatory or biomarker roles in cancer or other contexts)
05

Biomarkers

None specific (this pseudogene is not noted as a clinical biomarker; more generally, certain pseudogenes may have biomarker potential in cancer)

Beyond the preview

Go deeper on RP42 homolog pseudogene (RP42).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RP42 homolog pseudogene (RP42).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call